Pantoprazol Hennig (Pantoprazole Sodium Sesquihydrate)

Pantoprazole blocks the H+/K+‑ATPase enzyme, also known as the gastric proton pump, on the surface of stomach parietal cells. By irreversibly inhibiting this final step of acid secretion, it reduces both basal and stimulated gastric acidity, creating a less aggressive environment for the mucosa and allowing ulcer healing.

The specific dose of Pantoprazol Hennig is determined by the prescribing clinician based on the patient’s condition, severity and response to therapy. Healthcare professionals set the appropriate strength, frequency and duration according to current clinical guidelines and individual patient needs.

Pantoprazol Hennig may be used during pregnancy or lactation only when the potential benefit outweighs any possible risk to the fetus or infant. Clinicians should evaluate each case individually and follow local regulatory guidance, as limited data are available for long‑term exposure in these populations.

To request Pantoprazol Hennig, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Pantoprazol Hennig is a proton pump inhibitor similar to omeprazole, esomeprazole and lansoprazole. All share the same mechanism of inhibiting the gastric proton pump, but differences exist in pharmacokinetic profiles, drug‑interaction potential and dosing convenience. Pantoprazole is often chosen for its lower propensity to interact with CYP‑mediated drugs.

Pantoprazol Hennig tablets should be stored at temperatures below 25 °C, in the original packaging, protected from moisture and direct sunlight. Maintaining these conditions helps preserve the tablet’s stability and potency throughout its shelf life.

Pantoprazol Hennig is taken orally, usually as a whole tablet with a glass of water. It can be taken with or without food, but consistent daily timing helps maintain steady acid suppression. Patients should follow the prescriber’s instructions regarding dose and duration.

Serious risks, though uncommon, include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated diarrhoea, low magnesium levels, bone fractures with long‑term use, liver enzyme elevations and acute interstitial nephritis. Patients should report any unusual symptoms promptly to their healthcare provider.

Pantoprazol Hennig is contraindicated in individuals with known hypersensitivity to pantoprazole or other proton pump inhibitors. Caution is also advised for patients with severe liver disease, those taking certain interacting medications, and anyone for whom acid suppression is not medically indicated.